StockData
Provectus Biopharmaceuticals, Inc. logo

Provectus Biopharmaceuticals, Inc. (PVCT) stock

PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$0.05+0.00 (+0.39%)

Close on Oct 19, 2026Market cap $20.55MP/E –Yield –

Provectus Biopharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Provectus Biopharmaceuticals

Provectus Biopharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Provectus Biopharmaceuticals figures

See a number that looks wrong?